Osteopenia and Conjunctivitis
Summary:
Conjunctivitis is found among people with Osteopenia, especially for people who are female, 60+ old.
The study analyzes which people have Conjunctivitis with Osteopenia. It is created by eHealthMe based on reports of 136 people who have Osteopenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Osteopenia?
Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,445 drugs and 1,170 conditions by eHealthMe. Check the latest studies of Osteopenia.
What is Conjunctivitis?
Conjunctivitis (pink eye) is found to be associated with 1,298 drugs and 1,639 conditions by eHealthMe. Check the latest studies of Conjunctivitis.
136 people who have Osteopenia and Conjunctivitis are studied.

Gender of people who have Osteopenia and experienced Conjunctivitis *:
Age of people who have Osteopenia and experienced Conjunctivitis *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Conjunctivitis?
- Check whether Conjunctivitis is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Osteopenia (46,948 reports)
- Conjunctivitis (22,439 reports)
All the drugs that are associated with Conjunctivitis:
- Conjunctivitis (1,298 drugs)
All the conditions that are associated with Conjunctivitis:
- Conjunctivitis (1,639 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Conjunctivitis and Osteopenia, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Atarax cause Hypomania? - 4 seconds ago
- Could Zelboraf cause Influenza Like Illness? - 7 seconds ago
- Drug interactions of Piperacillin And Tazobactam and Metformin - 8 seconds ago
- Could Fludara cause Skin Toxicity? - 16 seconds ago
- Could Symdeko cause The Flu? - 17 seconds ago
- Could Metoprolol Tartrate cause Device Related Infection? - 24 seconds ago
- Drug interactions of Coreg and Golytely - 25 seconds ago
- Adderall Xr 30 vs. Methylin Er, side effect and effectiveness comparison - 30 seconds ago
- Drug interactions of Provigil and Pentoxifylline - 35 seconds ago
- Caduet vs. Valsartan And Hydrochlorothiazide, side effect and effectiveness comparison - 42 seconds ago